Stem cell jab could replace surgery for painful thumb arthritis
NCT ID NCT05708430
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the safety of injecting a patient's own stem cells (from fat tissue) into the thumb joint to treat painful thumb arthritis when standard treatments have failed. The goal is to see if this injection can control the disease and avoid the need for surgery. The trial involves 12 adults with moderate thumb arthritis who are already candidates for surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Rhizarthrosis DELL stage 1 to 3 * Symptomatic medical treatment for a period of at least 6 months (analgesic, orthosis, anti-inflammatory, etc. or intra-articular infiltration of the trapezio-metacarpal joint) which has become ineffective (surgical stage) * EVA pain ≥ 4 * Quick Dash or PRWHE ≥ 20/100 * Affiliation to a social security scheme * Person who has read and understood the information letter and signed the consent form Exclusion Criteria: * History of intra-articular injection of the trapezio-metacarpal (corticoid or hyaluronic acid) in the last 6 months * Body Mass Index \< 18 kg/m2 * Contraindication to general or local anesthetics including XYLOCAINE 10 mg/mL ADRENALINE 0.005 mg/mL, solution for injection * Contraindication to sedation or general anesthesia (left to the discretion of the anesthesiologist) * Contraindication to liposuction (eg bleeding disorder) * Documented severe allergy to conventional antibiotics such as β-lactams, cyclins, macrolides, quinolones, aminoglycosides, etc… * Known hypersensitivity to human albumin or to any of the excipients (VIALEBEX 200 g/L, solution for infusion) * A general or local infection near the sampling or injection sites * Any surgery scheduled over the duration of the study of the hand (carpal tunnel type operation) or upper limb that may have an impact on the assessment of pain and/or functional indices * Persons on immunosuppressants: corticosteroid therapy \> 10 mg/d, methotrexate \> 25 mg/week, mycofenolate mofetil \> 3 grams/d, azathioprine \> 200 mg/d and intravenous cyclophosphamide and any biotherapy in the 90 days preceding the medical visit. inclusion * Congenital or acquired immune deficiency * Prescription of a new systemic treatment that may influence the condition of the hand (vasodilator or immunosuppressant) in the 90 days preceding inclusion * Persons infected with HIV, HCV, HBV, HTLV and syphilis * Contraindication to MRI, (eg, due to presence of pacemakers or other incompatible foreign material or claustrophobia) * Contraindication to the injection of gadolinated contrast product (gadolinium) for performing MRI (history of hypersensitivity to gadolinated contrast products) * Active COVID-19 infection (PCR positive) * Any cardiovascular, metabolic, endocrine, psychiatric or cancerous pathology in uncontrolled evolution
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rhizarthrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU CAEN
RECRUITINGCaen, 14033, France
-
Chu Amiens
RECRUITINGAmiens, 80054, France
-
Chu Rouen
RECRUITINGRouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.